Lacerta Technologies is a regenerative medicine company located in Krems/Austria. We are funded through private capital as well as through the SEED financing program of Austria Wirtschaftsservice and regional funding from accent Gründerservice.
Lacerta Technologies is developing a coating technology for bone grafts that can induce stem cell proliferation and achieve a better remodeling. Since we do not use any exogenous growth factors or stem cells, our technology is easy to implement and affordable.
New management member -
CBO Peter Amersdorfer, Ph.D.